MYND Life Sciences Inc. (CSE:MYND)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
At close: May 1, 2025
MYND Life Sciences Market Cap
MYND Life Sciences has a market cap or net worth of CAD 5.22 million as of October 30, 2026. It is the 45,953rd most valuable company in the world and the 1,890th biggest in Canada. Its market cap has increased by 211.80% in one year.
Market Cap
5.22M
Enterprise Value
8.22M
Revenue
1.00
Global Rank
Country Rank
#1,890 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 26, 2021, MYND Life Sciences's market cap has decreased from 98.76M to 5.22M, a decrease of -94.72%. That is a compound annual growth rate of -52.64%.
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 5.22M | 9.13% |
| Dec 27, 2024 | 4.78M | 150.00% |
| Dec 22, 2023 | 1.91M | 2.14% |
| Dec 30, 2022 | 1.87M | -85.12% |
| Dec 31, 2021 | 12.58M | -87.26% |
| May 26, 2021 | 98.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 8.86M |
| COSCIENS Biopharma | 8.73M |
| Rakovina Therapeutics | 8.47M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 7.18M |
| PharmaTher Holdings | 5.01M |
| Restart Life Sciences | 4.06M |
| Grey Matters Health | 3.90M |